INTRODUCTION
H ost defense peptides (HDPs) represent a heterogeneous group of positively charged, amphipathic molecules composed of 12 to 50 amino acids, with diversity of properties. They are found in almost all living organisms, from bacteria to humans (1) . HDPs have multiplicity of biological functions. They exert a broad-spectrum antimicrobial activity and therefore are often referred to as "natural antibiotics" (2) . The structure and positive net charge of HDPs enable strong binding to negatively charged membranes of microorganisms, as well as cancer cells, that bear more negative net charge than healthy cell (3) . Electrostatic binding to outer surface of cell is followed by disruption of membrane structure, binding to vital intracellular molecules and interference with synthesis of macromolecules, resulting in cell death.
Although the most studied feature of HDPs is their antimicrobial activity, there are opinions that primary task of these peptides is immunomodulation. HDPs promote immune response to inflammation and at the same time restrain it, protecting organism from excessive reaction that can be detrimental for the host (4). They have impact on both innate and adaptive immunity and coordinate their action, influencing various processes, such as proliferation, chemotaxis, cytokine production and activation of adaptive immune response. Furthermore, HDPs participate in wound healing and neovascularization (5).
Currently, potential of HDPs as new therapeutic agents in infectious diseases, cancer and immune-related disorders is objective of increasing number of studies (6) . However, although recognized as promising new drugs, there are some limitations for their use. These referre to their sensitivity to enzymatic degradation and inactivation in serum by albumins and low-density lipoproteins, inadequate tissue distribution and potential systemic toxicity owning to their inefficient specificity. To overcome these problems, modifications of peptide structure have been under study (7).
In the present study we have tested effects of five peptides, selected on the basis of their high antimicrobial potency and low hemolytic activity. Naturally occurring peptides Brevinin-2GU (8) and brevinin-2-related peptide-ERa (B2RP-ERa) (9) were isolated from the skin of the Asian frog Hylarana. Analogs [D4k]ascaphin-8, [G4K]XT-7 (10-12) and [T5k]temporin-DRa (13), showing potent antimicrobial and low hemolytic activity, were derived from frog skin peptides that have shown broadspectrum antibacterial activity, but high hemolytic activity.
MATERIALS AND METHODS

Peptides
Brevinin-2GU (GVIIDTLKGAAKT VAAELLRKA-HCKLTNSC), B2RP-ERa (GVIKSVLKGVAKTVAL-GML.NH2), [D4k]ascaphin-8 (GFKkLLKGA AKA LV-KTVLF.NH2), [G4K]XT-7 (GLLKPLLKIAAKVGSN LL.NH2) and [T5k]temporin-DRa (HFLGkLVNLAK-KILNH2), supplied in crude form by GL Biochem Ltd. (Shanghai, China) and purified to near homogeneity by reverse-phase HPLC (>98%), were a gift from Dr. M. Conlon (United Arab Emirates University, Dubai, UAE).
Cell isolation and culture
Cells were isolated from peripheral blood of healthy volunteers. Our institutional Ethics Committee approved the study and prior to initiation written informed consent was obtained from all subjects according to the Declaration of Helsinki. Peripheral blood mononuclear cells (PBMNC) were isolated by density gradient centrifugation (Histopaque 1077, Sigma, Germany), washed three times and finally suspended in the supplemented culture medium RPMI 1640 (Sigma, Germany). Lymphocyte population (PBL) was isolated from PBMNC by adherence method (14). Cell number and viability were determined using Acridine orange/Ethidium bromide staining (all from Sigma, Germany).
Cell viability and proliferation assay
The effect of cationic peptides on peripheral blood mononuclear cells was determined by MTT assay that is widely used for assessing cell proliferation, cell viability, and/or cytotoxicity (15). Mononuclear cells or lymphocytes were grown in 96-well plates at a starting density of 0.2x10 6 cells/well in presence of increasing doses (1, 5, 10 and 20 μg/ml) of peptides or in medium alone (control). In some experiments Concanavalin A (ConA) was used (5μg/ml). Cells were cultured for 24h at 37°C in 5% C0 2 . Cultured cells viability was determined by assaying the reduction of MTT to formazan.
Statistics
The data were expressed as the mean ± SD. The distributions of data were evaluated for normality using the Kolmogorov-Smirnov test. One-way ANOVA was performed to compare parametric data between more than two groups. When ANOVA indicated significant differences, the Bonferroni test was used to identify intergroup differences. All statistical analyses were carried out with commercial statistical software (SPSS version 13.0; SPSS Inc., Chicago, IL).
RESULTS
The effect of peptides on cell viability
As shown in Figure 1 ., naturally occurring peptide Brevinin-2GU was slightly cytotoxic for PBMNC and PBL, but only the highest concentration (20μg/ml) decreased PBMNC viability with statistical significance (p<0.05), whereas effect on PBL was similar, but with no statistical significance. The other naturally occurring peptide, B2RP-ERa, didn't show significant cytotoxicity toward PBMNC. However, it demonstrated opposite effect on PBL, inducing cell proliferation reaching statistical significance with the highest concentrations of 10 and 20μg/ml (p<0.05 Peripheral blood mononuclear cells (PBMNC) and purified lymphocytes (PBL) were incubated for 24h in media alone (control) and with increasing doses (1, 5, 10 and 20 μg/ml) of peptides. Cytotoxic or proliferative effect of peptides is presented as percent of change in cell number related to control. The values represent the mean (±SD) of five different experiments. *p<0.05; **p<0.001
Peptides diminished mitogenic effect of ConA
To determine whether tested peptides have influence on proliferative response induced by Concanavalin A, PBLs were incubated in media alone (control), or treated with 5μg/ml ConA, either in absence or presence of different concentration of peptides. Our results showed that peptides decrease the mitogenic action of ConA ( Figure  2 .), and this effect was dose-dependent in that way that increase in concentration of peptides resulted in enhanced inhibition of ConA induced PBL proliferation.
Peripheral blood lymphocytes (PBL) were incubated for 24h in media alone (control) and with Concanavalin A (Con A) (5μg/ml) either in presence or absence of peptides (1, 5, 10 and 20 μg/ml). Proliferative response induced by ConA and influence of tested peptides on the response are presented as percent of change in cell number related to control. The values represent the mean (±SD) of five different experiments. *p<0.05
The most potent immunomodulator of all was Brevinin-2GU, that at the highest concentrations (10 and 20μg/ml) significantly inhibited ConA-induced proliferation of PBL, and this effect was most pronounced at a concentration of 20μg/ml which almost completely nullifies the effect of ConA (p<0.05). Other peptides showed a similar effect, but statistically significant inhibition of the mitogenic action of Con A, although somewhat less than the Brevinin-2GU, showed only the highest concentrations (10 and 20μg/ml) of naturally occurring peptide B2RP-ERa and analog [T5k]temporin-DRa (p<0.05).
Summarized results are presented in Figure 3 .
The effects of host defense peptides on peripheral blood mononuclear cells. 
Host defense peptides: potential new therapeutics
DISCUSSION
In spite of great potential of HDPs as new therapeutics, development of HDP-based drugs is limited by several shortcomings, such as instability and insufficient specificity. Therefore, a number of investigations are directed toward designing analogs of naturally occurring peptides that will outpass these disadvantages. In this study we have investigated effect of two naturally occurring peptides and three analogs on healthy peripheral blood mononuclear cells.
Our results showed that, apart from Brevinin-2GU that was cytotoxic in the highest concentration, tested HDP analogs and naturally occurring peptide B2RP-ERa didn't exhibit cytotoxicity against mononuclear cells isolated from peripheral blood, but rather promoted their proliferation. Our results are consistent with reports certifying that HDPs can enhance proliferation of peripheral blood mononuclear cells (16), which is in accordance with findings about impact of HDPs on immune system response (17). Activated lymphocytes can be, however, more sensitive to HDPs. The foregoing results have shown that tested peptides had more pronounced effect on macrophage depleted peripheral blood mononuclear cells (PBL). Macrophages are necessary for many lymphocyte functions, including activation and mitogenic response, but can also suppress lymphocyte activation. Furthermore, macrophages can uptake culture medium with peptides via endocytosis and thus reduce their concentration beneath the effective doses required for the effect observed on lymphocytes. Therefore, to exclude influence of macrophages and to test effect of peptides on activated lymphocytes, we incubated PBLs with T-cell mitogen ConA, alone or with different concentration of tested peptides.
All tested peptides decreased proliferative effect of ConA in that way that higher concentration of peptides resulted in higher inhibition. This effect was most prominent with naturally occurring peptides Brevinin-2GU and B2RP-ERa and analog [T5k]temporin-DRa (p<0.05). This effect of tested peptides can be a result of their cytotoxicity against activated lymphocytes. Nevertheless, in our previous study we have shown that tested peptides inhibited release of proinflammatory cytokines TNFα and IFNγ and stimulated release of antiinflammatory cytokines IL-4, IL-10 and TGFβ in ConA-stimulated PBLs (18). It is well known that IL-4, IL-10 and TGFβ can promote cell-cycle arrest and apoptosis (19, 20) .
Therefore it is possible that tested peptides exert their antiproliferative activity through stimulation of antiinflammatory cytokines release. In any case, these results point to their capability to influence immune response.
In conclusion, we have shown that tested peptides (except Brevinin-2GU) are not cytotoxic for resting peripheral blood mononuclear cells and even induce cell proliferation, and that both naturally occurring peptides and analog [T5k]temporin-DRa have potential to modulate immune response to the activation stimulus. Concerning their high antimicrobial potency and low hemolytic activity, these peptides can be considered as potential therapeutics.
